Methods of international health technology assessment agencies for economic evaluations- a comparative analysis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The number of Health Technology Assessment (HTA) agencies increases. One component of HTAs are economic aspects. To incorporate economic aspects commonly economic evaluations are performed. A convergence of recommendations for methods of health economic evaluations between international HTA agencies would facilitate the adaption of results to different settings and avoid unnecessary expense. A first step in this direction is a detailed analysis of existing similarities and differences in recommendations to identify potential for harmonization. The objective is to provide an overview and comparison of the methodological recommendations of international HTA agencies for economic evaluations. METHODS: The webpages of 127 international HTA agencies were searched for guidelines containing recommendations on methods for the preparation of economic evaluations. Additionally, the HTA agencies were requested information on methods for economic evaluations. Recommendations of the included guidelines were extracted in standardized tables according to 13 methodological aspects. All process steps were performed independently by two reviewers. RESULTS: Finally 25 publications of 14 HTA agencies were included in the analysis. Methods for economic evaluations vary widely. The greatest accordance could be found for the type of analysis and comparator. Cost-utility-analyses or cost-effectiveness-analyses are recommended. The comparator should continuously be usual care. Again the greatest differences were shown in the recommendations on the measurement/sources of effects, discounting and in the analysis of sensitivity. The main difference regarding effects is the focus either on efficacy or effectiveness. Recommended discounting rates range from 1.5%-5% for effects and 3%-5% for costs whereby it is mostly recommended to use the same rate for costs and effects. With respect to the analysis of sensitivity the main difference is that oftentimes the probabilistic or deterministic approach is recommended exclusively. Methods for modeling are only described vaguely and mainly with the rational that the "appropriate model" depends on the decision problem. Considering all other aspects a comparison is challenging as recommendations vary regarding detailedness and addressed issues. CONCLUSION: There is a considerable unexplainable variance in recommendations. Further effort is needed to harmonize methods for preparing economic evaluations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
Briggs, A. H., Weinstein, M. C., Fenwick, E. A. L., Karnon, J., Sculpher, M. J., & Paltiel, A. D. (2012) · Value in Health · doi:10.1016/j.jval.2012.04.014 · Cited by 823
Mant, J., Doust, J., Roalfe, A., Barton, P., Cowie, M., Glasziou, P., Mant, D., McManus, R., Holder, R., Deeks, J., et al. (2009) · Health Technology Assessment · doi:10.3310/hta13320 · Cited by 498
Cited by
Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety
Huckvale, K., Venkatesh, S., & Christensen, H. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0166-1 · Cited by 433
National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison
Sharma, D., Aggarwal, A. K., Downey, L. E., & Prinja, S. (2021) · PharmacoEconomics - Open · doi:10.1007/s41669-020-00250-7 · Cited by 114
“With growing interest internationally in the use of HTA, new guidelines have been developed in Asian and African nations that have not been captured in earlier reviews [23, 24].”
BackgroundArmstrong, K. A., Semple, J. L., & Coyte, P. C. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.3528 · Cited by 105
“HTA agencies recommend conducting a systematic review of the literature on key model inputs including effect data; however, clinical trials and observational studies can be used to obtain effect data if they more appropriately represent the model of interest [10].”
MethodInfluentialSeries: Pragmatic trials and real world evidence: Paper 5. Usual care and real life comparators
Zuidgeest, M. G. P., Welsing, P. M. J., van Thiel, G. J. M. W., Ciaglia, A., Alfonso-Cristancho, R., Eckert, L., Eijkemans, M. J. C., & Egger, M. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.07.001 · Cited by 59
Metadata
- Authors
- Mathes, T., Jacobs, E., Morfeld, J.-C., & Pieper, D.
- Venue
- BMC Health Services Research
- Published
- 2013-09-30
- Volume
- 13
- Issue
- 1
- Pages
- 371-371
- ISSN
- 1472-6963 (ISSN-L)
- OpenAlex
- W1970708247
- Cited by
- 87
- References
- 3
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Methods of international health technology assessment agencies for economic evaluations- a comparative analysis. https://app.cochat.ai/papers/10.1186/1472-6963-13-371
- The paper
- Mathes, T., Jacobs, E., Morfeld, J.-C., & Pieper, D. (2013). Methods of international health technology assessment agencies for economic evaluations- a comparative analysis. BMC Health Services Research. https://doi.org/10.1186/1472-6963-13-371
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.